Ehret Felix, Bhandarkar Archis R, Chisam Michael, Goulenko Victor, Kumar Ritesh, Fekrmandi Fatemeh, Skalina Karin A, Kresl John, Lo Simon S, Gibbs Iris C, Soltys Scott G, Sheehan Jason P, Fürweger Christoph, Slotman Ben J, Shih Helen A, Chao Samuel T
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany; European Radiosurgery Center Munich, Munich, Germany.
Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota.
Pract Radiat Oncol. 2025 Jul-Aug;15(4):335-346. doi: 10.1016/j.prro.2025.01.010. Epub 2025 Feb 3.
Vestibular schwannomas (VS) are the most common benign intracranial nerve sheath tumors. Surgery and radiation therapy - particularly stereotactic radiosurgery (SRS) - are the primary treatment options. SRS is the dominant treatment for small- and medium-sized VS and selected larger tumors due to its excellent local control rates and favorable safety profile compared with surgery. However, careful treatment planning is essential, taking into account patient preferences, tumor location and size, symptoms, and anticipated treatment-related toxicity.
Four clinical VS scenarios have been selected to illustrate the use of SRS, including a unilateral small intracanalicular VS, a large VS with cystic components, reirradiation with SRS after local tumor recurrence, and bilateral VS in the setting of neurofibromatosis type 2-related schwannomatosis.
SRS is an effective and safe treatment modality for the majority of VS cases, requiring careful treatment planning and a thorough understanding of potential limitations and challenges.
This case-based practice guide aims to provide a concise overview of the treatment of VS with SRS. We present and discuss 4 different clinical scenarios of VS to highlight the pitfalls and best practice recommendations.
前庭神经鞘瘤(VS)是最常见的颅内良性神经鞘瘤。手术和放射治疗——尤其是立体定向放射外科治疗(SRS)——是主要的治疗选择。由于与手术相比,SRS具有出色的局部控制率和良好的安全性,因此它是中小型VS以及部分较大肿瘤的主要治疗方法。然而,在制定治疗方案时必须谨慎考虑患者的偏好、肿瘤的位置和大小、症状以及预期的治疗相关毒性。
选择了四种临床VS病例来阐述SRS的应用,包括单侧小听道内VS、伴有囊性成分的大VS、局部肿瘤复发后采用SRS进行再照射以及2型神经纤维瘤病相关神经鞘瘤病背景下的双侧VS。
对于大多数VS病例,SRS是一种有效且安全的治疗方式,需要精心的治疗规划以及对潜在局限性和挑战的透彻理解。
本基于病例的实践指南旨在简要概述采用SRS治疗VS的方法。我们展示并讨论了4种不同的VS临床病例,以突出其中的陷阱和最佳实践建议。